Selective sentinel lymphadenectomy for human solid cancer
(eBook)

Book Cover
Published:
New York : Springer, [2005].
Format:
eBook
ISBN:
9780387236049, 038723604X, 0387236031, 9780387236032
Content Description:
1 online resource (xxiii, 297 pages) : illustrations (some color).
Status:
Available Online
Description

In human solid cancer, the lymph node (LN) status is the most important prognostic indicator for the clinical outcome of patients. Various developments in the sentinel lymph node (SLN) concept and technology have resulted in the application of this revolutionary approach to define the draining or SLN to which the cancer may have metastasized.

Copies
CCU Electronic Resources
More Like This
Citations
APA Citation (style guide)

Leong, S. P. L., Kitagawa, Y., & Kitajima, M. (2005). Selective sentinel lymphadenectomy for human solid cancer. New York, Springer.

Chicago / Turabian - Author Date Citation (style guide)

Leong, Stanley P. L, Yuko. Kitagawa and Masaki Kitajima. 2005. Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York, Springer.

Chicago / Turabian - Humanities Citation (style guide)

Leong, Stanley P. L, Yuko. Kitagawa and Masaki Kitajima, Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York, Springer, 2005.

MLA Citation (style guide)

Leong, Stanley P. L., et al. Selective Sentinel Lymphadenectomy for Human Solid Cancer. New York, Springer, 2005.

Note! Citation formats are based on standards as of July 2022. Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy.
More Copies In Prospector
Loading Prospector Copies...
More Details
Language:
English

Notes

Bibliography
Includes bibliographical references and index.
Description
In human solid cancer, the lymph node (LN) status is the most important prognostic indicator for the clinical outcome of patients. Various developments in the sentinel lymph node (SLN) concept and technology have resulted in the application of this revolutionary approach to define the draining or SLN to which the cancer may have metastasized.
Staff View
Grouped Work ID:
e8ce24fd-09d1-5e65-221b-89f7bedadd00
Go To GroupedWork

Record Information

Last Sierra Extract TimeMar 06, 2024 02:43:10 AM
Last File Modification TimeMar 06, 2024 02:43:33 AM
Last Grouped Work Modification TimeApr 05, 2024 08:32:16 AM

MARC Record

LEADER05994cam a2200901Ia 4500
001262680010
003OCoLC
00520150609070555.8
006m     o  d        
007cr cn|||||||||
008081017s2005    nyua    ob    001 0 eng d
019 |a 74819427|a 225868155|a 228399525|a 316868866|a 320959702|a 401411240|a 546566409|a 647529900|a 690020118|a 698450395|a 746953532|a 756538947|a 767166664
020 |a 9780387236049
020 |a 038723604X
020 |a 0387236031
020 |a 9780387236032
035 |a (OCoLC)262680010|z (OCoLC)74819427|z (OCoLC)225868155|z (OCoLC)228399525|z (OCoLC)316868866|z (OCoLC)320959702|z (OCoLC)401411240|z (OCoLC)546566409|z (OCoLC)647529900|z (OCoLC)690020118|z (OCoLC)698450395|z (OCoLC)746953532|z (OCoLC)756538947|z (OCoLC)767166664
037 |a 978-0-387-23603-2|b Springer|n http://www.springerlink.com
040 |a GW5XE|b eng|e pn|c GW5XE|d VAM|d N$T|d YDXCP|d HNK|d UAB|d CNTRU|d E7B|d OCLCQ|d MHW|d IDEBK|d OCLCQ|d YNG|d ISOBC|d OCLCO|d EBLCP|d OCLCQ|d A7U|d OCLCQ|d OCLCA|d OCLCF|d NLGGC|d OCLCQ|d OCLCO|d AZU
049 |a COM6
050 4|a RC280.L9|b S455 2005eb
060 4|a W1|b CA693 v.127 2005
060 4|a WH 700|b S464 2005
072 7|a RC|2 lcco
072 7|a MED|x 062000|2 bisacsh
072 7|a HEA|x 039030|2 bisacsh
08204|a 616.99/446|2 22
24500|a Selective sentinel lymphadenectomy for human solid cancer|h [electronic resource] /|c edited by Stanley P.L. Leong, Yuko Kitagawa, Masaki Kitajima.
264 1|a New York :|b Springer,|c [2005]
264 4|c ©2005
300 |a 1 online resource (xxiii, 297 pages) :|b illustrations (some color).
336 |a text|b txt|2 rdacontent
337 |a computer|b c|2 rdamedia
338 |a online resource|b cr|2 rdacarrier
4901 |a Cancer treatment and research
504 |a Includes bibliographical references and index.
5050 |a The development of lymphatic mapping and selective lymphadenectomy: a historical perspective -- Role of lymphoscintigraphy for selective sentinel lymphadenectomy -- Selective sentinel lymphadenectomy for malignant melanoma, merkel cell carcinoma, and squamous cell carcinoma -- Selective sentinel lymphadenectomy for breast cancer -- Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls -- Sentinel lymph node mapping in esophageal and gastric cancer -- Sentinel lymph node mapping in lung cancer -- Lymphatic mapping and sentinel lymphadenectomy in urology -- Selective sentinel lymphadenectomy for gynecologic cancer -- Selective sentinel lymphadenectomy for head and ncek squamous cell carcinoma -- Accurate evaluation of nodal tissues for the presence of tumor is central to the sentinel node approach -- Molecular diagnosis of micrometastasis in the sentinel lymph node -- Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy -- Selective sentinel lymphadenectomy: progress to date and prospects for the future.
520 |a In human solid cancer, the lymph node (LN) status is the most important prognostic indicator for the clinical outcome of patients. Various developments in the sentinel lymph node (SLN) concept and technology have resulted in the application of this revolutionary approach to define the draining or SLN to which the cancer may have metastasized.
5880 |a Print version record.
650 0|a Lymphatic metastasis.|0 https://id.loc.gov/authorities/subjects/sh85079131
650 0|a Lymph nodes|x Biopsy.|0 https://id.loc.gov/authorities/subjects/sh2010002399
650 0|a Tumors|v Classification.|0 https://id.loc.gov/authorities/subjects/sh85138555
650 7|a MEDICAL|x Oncology.|2 bisacsh
650 7|a HEALTH & FITNESS|x Diseases|x Cancer.|2 bisacsh
650 7|a Lymph nodes|x Biopsy.|2 fast|0 (OCoLC)fst01004266
650 7|a Lymphatic metastasis.|2 fast|0 (OCoLC)fst01004277
650 7|a Tumors.|2 fast|0 (OCoLC)fst01158759
65012|a Public Health.|0 https://id.nlm.nih.gov/mesh/D011634
65020|a Cancer|x Surgery.|0 https://id.loc.gov/authorities/subjects/sh85019545
650 2|a Sentinel Lymph Node Biopsy|x methods.|0 https://id.nlm.nih.gov/mesh/D021701Q000379
650 2|a Lymphatic Metastasis|x diagnosis.|0 https://id.nlm.nih.gov/mesh/D008207Q000175
650 2|a Neoplasm Staging|x methods.|0 https://id.nlm.nih.gov/mesh/D009367Q000379
650 2|a Neoplasms|x diagnosis.|0 https://id.nlm.nih.gov/mesh/D009369Q000175
655 7|a Classification.|2 fast|0 (OCoLC)fst01697073
655 7|a Classification.|2 lcgft
7001 |a Leong, Stanley P. L.|0 https://id.loc.gov/authorities/names/n88220881
7001 |a Kitagawa, Yuko.|0 https://id.loc.gov/authorities/names/n2005180417
7001 |a Kitajima, Masaki,|d 1941-2019.|0 https://id.loc.gov/authorities/names/n89141008
7102 |a SpringerLink (Online service)|0 https://id.loc.gov/authorities/names/no2005046756
7730 |t Springer e-books
77608|i Print version:|t Selective sentinel lymphadenectomy for human solid cancer.|d New York : Springer, ©2005|z 0387236031|z 9780387236032|w (DLC) 2005042506|w (OCoLC)57557318
830 0|a Cancer treatment and research.|0 https://id.loc.gov/authorities/names/n42005764
907 |a .b29535748
948 |a MARCIVE Comp, in 2022.12
948 |a MARCIVE Comp, 2020.03
948 |a MARCIVE Comp, 2018.05
948 |a MARCIVE Comp, 2017.10
948 |a MARCIVE August, 2017
948 |a MARCIVE extract Aug 5, 2017
989 |1 .i7174714x|d cceb|g j|m |h 0|x 0|t 0|i 0|j 188|k 120614|o -|w SpringerLink CCU Owned|u http://ezproxy.ccu.edu/login?url=http://dx.doi.org/10.1007/b101891
994 |a 92|b COM
995 |a Loaded with m2btab.ltiac in 2022.12
995 |a Loaded with m2btab.ltiac in 2020.03
995 |a Loaded with m2btab.ltiac in 2018.06
995 |a Loaded with m2btab.ltiac in 2017.10
995 |a Loaded with m2btab.ltiac in 2017.08
995 |a OCLC offline update by CMU
998 |e -|f eng|a cc